drugset / Trial / NCT02171117
Safety and Efficacy Study of Microtransplantation to Treat Elderly Acute Myeloid Leukemia
Phase 3
Unknown
196 enrolled
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
RandomizedSingle-groupOpen-labelTreatment
Summary
Patients enrolled from each center according to confirmed criteria specified in cooperative scheme are randomly assigned to standard induction and consolidation chemotherapy with microtransplantation （MST-group）or without (CT-group).Compare the remission rate and 2-year disease-free survival (DFS) and overall survival(OS) rate of the two groups.
Timeline
- Start
- 2014-03
- Primary completion
- 2018-06
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HLA-mismatched donor peripheral stem cell infusion | Cell therapy | — | — |